INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$12.1M

$12,127,717

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
AXSM M Axsome Therapeutics, Inc. Jacobson Mark L. • COO Other 2026-02-26 $100,827 View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO Other	2026-02-26	$100,827	M	Form 4
AXSM S Axsome Therapeutics, Inc. Jacobson Mark L. • COO 10b5-1 Sell 2026-02-26 $5,726,991Whale View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO 10b5-1 Sell	2026-02-26	$5,726,991Whale	S	Form 4
AXSM M Axsome Therapeutics, Inc. Jacobson Mark L. • COO Other 2025-09-22 $28,500 View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO Other	2025-09-22	$28,500	M	Form 4
AXSM S Axsome Therapeutics, Inc. Jacobson Mark L. • COO 10b5-1 Sell 2025-09-22 $1,159,600Large View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO 10b5-1 Sell	2025-09-22	$1,159,600Large	S	Form 4
AXSM M Axsome Therapeutics, Inc. Jacobson Mark L. • COO Other 2025-09-16 $196,500x2 View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO Other	2025-09-16	$196,500x2	M	Form 4
AXSM S Axsome Therapeutics, Inc. Jacobson Mark L. • COO 10b5-1 Sell 2025-09-16 $5,241,127Whalex2 View Form 4 →
AXSM	Axsome Therapeutics, Inc.	Jacobson Mark L. COO 10b5-1 Sell	2025-09-16	$5,241,127Whalex2	S	Form 4